Optimising remote monitoring in hybrid clinical trials
Hybrid clinical trials have become a cornerstone of modern research, blending the benefits of traditional on-site visits with the flexibility of remote data collection. This approach not only enhances patient convenience but also expands access to a broader and more diverse participant pool. However, managing these hybrid studies efficiently requires
The most read
Don’t miss the latest news on Xolomon
Optimising remote monitoring in hybrid clinical trials
Hybrid clinical trials have become a cornerstone of modern research, blending the benefits of traditional on-site visits with the flexibility of remote data collection. This approach not only enhances patient convenience but also expands access to a broader and more diverse participant pool. However, managing these hybrid studies efficiently requires robust remote monitoring capabilities, and this is where Xolomon’s platform
Advanced CTMS: Comprehensive lifecycle management for clinical studies with Xolomon
In the fast-paced world of clinical research, efficient management of study processes is crucial. From study planning and site selection to data collection, monitoring, and reporting, every stage must be meticulously coordinated. This is where a Clinical Trial Management System (CTMS) becomes indispensable. At Xolomon, our advanced CTMS offers a comprehensive solution that empowers research teams to manage every aspect
Ensuring data security in clinical trials: best practices
In the world of clinical research, data security is not just a priority: it is a necessity. Protecting patient data is essential for maintaining trust, ensuring compliance with regulatory standards, and safeguarding the integrity of study results. At Xolomon, we understand the critical importance of data security, and our platform is designed to provide researchers with a secure, compliant, and
TAUTEM study published in JAMA Surgery: A milestone in minimally invasive rectal cancer treatment
We are proud to share that the TAUTEM study, which utilised Xolomon’s electronic data capture (EDC) platform, has been published in JAMA Surgery, one of the most prestigious surgical journals worldwide, with an impact factor of 15.9. Led by Dr Xavier Serra-Aracil and his team, this multicentre, randomised clinical trial explored an alternative approach to rectal cancer treatment. The study
